Protean agonism at histamine H <sub>3</sub> receptors <i>in vitro</i> and <i>in vivo</i>
Florence Gbahou, Jean‐Michel Arrang(Université Claude Bernard Lyon 1), Jian‐Sheng Lin(Université Claude Bernard Lyon 1), Xavier Ligneau(Inserm), Walter Schunack(Université Claude Bernard Lyon 1), Séverine Morisset‐Lopez(Centre National de la Recherche Scientifique), Régis Parmentier(Université Claude Bernard Lyon 1), Holger Stark(Heinrich Heine University Düsseldorf), Jean-Charles Schwartz(Université Claude Bernard Lyon 1), A. Rouleau, Sylvain Crochet(École Polytechnique), J. Tardivel‐Lacombe(Université Claude Bernard Lyon 1), C. Robin Ganellin(University College London)
Cited by 142
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Anatomical, Physiological, and Pharmacological Characteristics of Histidine Decarboxylase Knock-Out Mice: Evidence for the Role of Brain Histamine in Behavioral and Sleep–Wake Control
|Journal of Neuroscience|2002|470
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264